SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients

Daryl Geers, Marc C. Shamier, Susanne Bogers, +22

Science Immunology

Divergent SARS-CoV-2 Omicron–reactive T and B cell responses in COVID-19 vaccine recipients

Corine H. GeurtsvanKessel, Daryl Geers, Katharina S. Schmitz, +21

Science Immunology

An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment

Corine H. GeurtsvanKessel, Nisreen M.A. Okba, Susanne Bogers, +12

Nature Communications

Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals

Luca M. Zaeck, Mart M. Lamers, Babs E. Verstrepen, +16

Nature Medicine

Healthy IndividualsImmunologyImmunodominanceImmunotherapeuticsMonkeypox Virus-neutralizing Antibodies +18

Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity

Leanne P. M. van Leeuwen, Corine H. GeurtsvanKessel, Pauline M. Ellerbroek, +34

Journal of Allergy and Clinical Immunology

Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial

Marcia M. L. Kho, A. Lianne Messchendorp, Sophie C. Frölke, +38

The Lancet Infectious Diseases

VaccinologyVaccinationTransplantationVaccine DevelopmentKidney Transplant +9

Virological characteristics of SARS-CoV-2 vaccine breakthrough infections in health care workers

Marc C. Shamier, Alma Tostmann, Susanne Bogers, +14

Viral DiagnosticsImmunologyHealth Care WorkersVirological CharacteristicsDelta Variant +14

Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study

Kathryn S. Hensley, Marlou J. Jongkees, Daryl Geers, +31

PLoS Medicine

Divergent SARS CoV-2 Omicron-specific T- and B-cell responses in COVID-19 vaccine recipients

Corine H. GeurtsvanKessel, Daryl Geers, Katharina S. Schmitz, +20

VaccinationVaccine DevelopmentCovid-19 Vaccine RecipientsMedicineVaccine Target +12

Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial

Ngoc H. Tan, Daryl Geers, Roos S. G. Sablerolles, +21

The Lancet Infectious Diseases

VaccinationVaccine SafetyDirect Boost GroupPreventive MedicineAllergy +7